Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 2/20 | 0.34 |
| ▸ | RXRB | P28702 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.30 |
| ▸ | KHK | P50053 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21534263 | 0.94 | L3MBTL1 (0.43) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21534292 | 0.94 | L3MBTL1 (0.43) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL17740637 | 0.93 | KDM4E (0.39) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21534335 | 0.91 | L3MBTL1 (0.45) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL13968614 | 0.91 | L3MBTL1 (0.45) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21534261 | 0.91 | L3MBTL1 (0.45) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL17720393 | 0.91 | L3MBTL1 (0.42) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL21534280 | 0.90 | L3MBTL1 (0.41) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL17250137 | 0.89 | L3MBTL1 (0.43) | KDM4EATML3MBTL1RXRARXRB | |
| SCHEMBL17720390 | 0.89 | L3MBTL1 (0.43) | KDM4EATML3MBTL1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210184128-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| US-20200144508-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200144508-A1 | ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OCIAD2, OR10J3 | KDM4E 4500/4885ATM 3249/4885L3MBTL1 3961/4885 |
| US-20210184128-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OR10J3, OCIAD1, OXER1 | KDM4E 3659/4885ATM 3686/4885L3MBTL1 4294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.